Anti-cytokine therapies in T1D Concepts and strategies

Anti-cytokine therapies in T1D : Concepts and strategies

Copyright © 2013 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 149(2013), 3 vom: 08. Dez., Seite 279-85
1. Verfasser: Nepom, Gerald T (VerfasserIn)
Weitere Verfasser: Ehlers, Mario, Mandrup-Poulsen, Thomas
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2013
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Review Anti-inflammatory Autoimmunity DAMPs IL-1 receptor accessory protein IL-1 receptor antagonist IL-1RA IL-1RAcP Immunotherapy mehr... LPS NOD ROS Regulatory T cells T1D T2D TLR TXNIP Teff Treg damage/danger-associated molecular patterns effector T cell(s) lipopolysaccharide non-obese diabetic (mice) reactive oxygen species regulatory T cell(s) thioredoxin inhibitory protein toll-like receptor type 1 diabetes type 2 diabetes Antibodies, Monoclonal Hypoglycemic Agents Interleukin-1 Interleukin-23 Interleukin-6 Tumor Necrosis Factor-alpha Interleukin-12 187348-17-0
Online verfügbar Volltext